Rhabdomyosarcoma and related pelvic tumors of the genitourinary tract

Miriam Harel, Fernando Ferrer

Research output: Chapter in Book/Report/Conference proceedingChapter


Rhabdomyosarcoma (RMS) represents the most common soft tissue sarcoma in infants and children, with approximately 350 new cases diagnosed in the United States each year. Of these, 15-20% arise from the genitourinary tract, the most common sites being the prostate, bladder, and paratesticular regions, followed by the vagina and uterus. A multimodal treatment approach includes systemic chemotherapy for all patients and local control involving surgical resection with or without radiation therapy. Currently, a principal goal of surgical management is organ preservation when possible. Despite improved overall survival, children with RMS continue to suffer from a wide range of treatment-related side effects and complications. Meticulous follow-up is required to assess the sequelae of current therapies.

Original languageEnglish (US)
Title of host publicationPediatric Urology
Subtitle of host publicationSurgical Complications and Management: Second Edition
Number of pages9
ISBN (Electronic)9781118473382
ISBN (Print)9781118473313
StatePublished - Apr 24 2015
Externally publishedYes


  • Bladder dysfunction
  • Genitourinary
  • Multimodal treatment
  • Pediatric
  • Rhabdomyosarcoma
  • Surgical complications

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Rhabdomyosarcoma and related pelvic tumors of the genitourinary tract'. Together they form a unique fingerprint.

Cite this